Mylan Sells Entire 5.64% Biocon Stake In Open Market Deal

15 July 2026

Biocon Ltd.

Mylan Inc (non-prom) sold 9.19Cr sh (5.64%) in Biocon via open mkt; before 9.19Cr, after nil.

Recent Events

Biocon Launches Yesafili Aflibercept Biosimilar in United States

Biocon Launches Yesafili Aflibercept Biosimilar Commercially In United States

Get features of